eResearch Technology (ERES): This healthcare penny stock specializes in providing technology and services to collect, interpret and distribute cardiac safety and clinical data to pharmaceutical and biotech firms. In plain English, eResearch functions as quality control for any prospective medication that hits the market. That’s a crucial business with almost limitless potential, especially as big pharma races to develop new drugs in its product pipeline. ERES stock is up 38% year-to-date and has a lot of room left to run.
Ballantyne Strong (BTN): Ballantyne is a leader in the transition to digital and 3-D theater technology. It is not a huge company, but their workforce in Omaha is honed and dedicated. its theatre segment, which accounts for nearly all of Ballantyne Strong’s revenue, BTN produces digital and film projectors, screens and accompanying systems. Ballantyne can completely outfit a theater, from top to bottom, and is becoming a one-stop shopping mall for folks who want to get a movie theater up-and-running, or to retrofit an older establishment with digital or 3-D technology. This penny stock has more than doubled so far in 2010 and is still looking red-hot.
Lionbridge Technologies (LIOX): Lionbridge provides language, development and testing services to businesses all over the world. In fact, its customers generate more than half of their revenue from outside of the United States. Most people automatically think of technology companies when they think about globalization. However, Lionbridge has clients not only in the technology sector, but also scores of businesses operating in almost every sector, including consumer packaged goods, biotech, publishing, banking and even in government agencies worldwide. This diversification allows Lionbridge a diverse customer base that minimize risk and maximize profits for shareholders. LIOX stock has more than doubled so far this year and remains a great investment.
No comments:
Post a Comment